IMTM - ETF AI Analysis
Top Page
iShares MSCI Intl Momentum Factor ETF (IMTM)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year, showing that its momentum-focused strategy has recently worked well.
High-Performing Top Holdings
Several of the largest positions, including ASML and Kioxia, have shown very strong performance, helping drive the fund’s returns.
Broad International Diversification
The fund spreads its investments across many countries and sectors, which helps reduce the impact of problems in any single market or industry.
Negative Factors
Heavy Country Concentration
A large share of the portfolio is invested in a few markets like Japan and the UK, which can increase risk if those economies face setbacks.
Sector Skew Toward Financials
Significant exposure to financial companies means the ETF could be more sensitive to banking and interest-rate shocks than a more balanced fund.
Moderate Expense Ratio
While not extremely high, the fund’s ongoing fee is meaningful and will slightly reduce investors’ net returns over time.
IMTM vs. SPDR S&P 500 ETF (SPY)
AUM4.23B
RegionDeveloped Markets
Expense Ratio0.30%
Beta0.84
IssueriShares
Inception DateJan 13, 2015
Dividend Yield4.45%
Asset ClassEquity
Index TrackedMSCI ACWI ex USA Momentum
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume412,471
30 Day Avg. Volume443,286
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
60.14Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering300
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IMTM Summary
The iShares MSCI Intl Momentum Factor ETF (IMTM) is a fund that follows the MSCI ACWI ex USA Momentum index, focusing on stocks outside the U.S. that have been rising in price recently. It holds companies from many countries and sectors, including well-known names like ASML Holding and HSBC. Investors might consider IMTM if they want international diversification and hope to benefit from stocks that are currently showing strong performance. However, because it focuses on momentum stocks, the ETF can be more volatile and can go up and down quickly with changes in global markets.
How much will it cost me?The iShares MSCI Intl Momentum Factor ETF (IMTM) has an expense ratio of 0.30%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to focus on momentum stocks, requiring more research and strategy. It’s still relatively affordable compared to other actively managed funds.
What would affect this ETF?The iShares MSCI Intl Momentum Factor ETF (IMTM) could benefit from strong economic growth in developed markets outside the U.S., particularly if sectors like financials and industrials, which make up a significant portion of its holdings, perform well. However, it may face challenges if global interest rates rise, as this could negatively impact financial stocks, or if geopolitical tensions disrupt international markets. The ETF's reliance on momentum investing also means it could underperform during periods of market volatility or sharp reversals in stock trends.
IMTM Top 10 Holdings
IMTM leans heavily on international financials and a few standout growth names, with banks like HSBC, Royal Bank of Canada, and Toronto-Dominion quietly powering the fund thanks to steady, rising share prices. European pharma giants Roche and Novartis add a more defensive, health care tilt, contributing stable gains rather than fireworks. ASML has been a key momentum engine over the year, even if its recent moves are more mixed. Meanwhile, memory-chip player Kioxia has been a rocket over the longer term but is currently losing altitude, slightly tugging on performance. Overall, the ETF is broadly diversified across developed markets outside the U.S., with a noticeable tilt toward global financials and select European and Asian growth stories.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 5.16% | $215.42M | €547.84B | 135.43% | 76 Outperform | |
| HSBC Holdings | 3.02% | $125.93M | £270.81B | 72.84% | 80 Outperform | |
| Royal Bank Of Canada | 2.46% | $102.66M | $290.61B | 62.00% | 75 Outperform | |
| Roche Holding AG | 1.96% | $81.78M | $348.49B | 38.24% | 73 Outperform | |
| Toronto Dominion Bank | 1.93% | $80.41M | $202.33B | 64.87% | 74 Outperform | |
| Novartis AG | 1.87% | $78.18M | CHF231.75B | 31.63% | 80 Outperform | |
| TotalEnergies SE | 1.71% | $71.33M | €170.58B | 50.93% | 78 Outperform | |
| Banco Santander | 1.70% | $70.92M | €180.75B | 65.23% | 73 Outperform | |
| Shell (UK) | 1.56% | $65.13M | £187.43B | 26.98% | 73 Outperform | |
| Advantest | 1.49% | $62.03M | ¥22.67T | 191.12% | 75 Outperform |
IMTM Technical Analysis
Positive
―
Price Trends
52.40
Positive
51.23
Positive
49.66
Positive
Market Momentum
0.03
Negative
56.27
Neutral
87.61
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IMTM, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 52.15, equal to the 50-day MA of 52.40, and equal to the 200-day MA of 49.66, indicating a bullish trend. The MACD of 0.03 indicates Negative momentum. The RSI at 56.27 is Neutral, neither overbought nor oversold. The STOCH value of 87.61 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IMTM.
IMTM Peer Comparison
Comparison Results
Performance Comparison
IMTM
iShares MSCI Intl Momentum Factor ETF
53.07
9.05
20.56%
GSIE
Goldman Sachs ActiveBeta International Equity ETF
―
―
―
LVHI
Legg Mason International Low Volatility High Dividend ETF
―
―
―
IDMO
Invesco S&P International Developed Momentum ETF
―
―
―
INTF
iShares MSCI Intl Multifactor ETF
―
―
―
PXF
Invesco FTSE RAFI Developed Markets ex-U.S. ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents